Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
International Journal of Hematology
|
February 19, 2011
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
Takayoshi Tachibana, Masatsugu Tanaka, Hirotaka Takasaki, et al.
International Journal of Hematology
|
January 22, 2010
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions
Takuya Miyazaki, Yohei Kirino, Mitsuhiro Takeno, et al.
Leukemia Research
|
August 10, 2013
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Reina Watanabe, Naoto Tomita, Kumiko Kishimoto, et al.
Medical Oncology (Northwood, London, England)
|
August 22, 2014
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy
Yuki Nakajima, Naoto Tomita, Reina Watanabe, et al.
European Journal of Haematology
|
November 29, 2013
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era
Reina Watanabe, Naoto Tomita, Megumi Itabashi, et al.
Leukemia Research
|
December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy
Yuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.
Leukemia & Lymphoma
|
June 11, 2014
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone
Naoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 15, 2015
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy]
Hideyuki Koharazawa, Reina Watanabe, Yukako Hattori, et al.
Cancer Science
|
November 3, 2011
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.
Leukemia & Lymphoma
|
June 9, 2017
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis
Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
International Journal of Hematology
|
February 19, 2011
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
Takayoshi Tachibana, Masatsugu Tanaka, Hirotaka Takasaki, et al.
International Journal of Hematology
|
January 22, 2010
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions
Takuya Miyazaki, Yohei Kirino, Mitsuhiro Takeno, et al.
Leukemia Research
|
August 10, 2013
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Reina Watanabe, Naoto Tomita, Kumiko Kishimoto, et al.
Medical Oncology (Northwood, London, England)
|
August 22, 2014
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy
Yuki Nakajima, Naoto Tomita, Reina Watanabe, et al.
European Journal of Haematology
|
November 29, 2013
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era
Reina Watanabe, Naoto Tomita, Megumi Itabashi, et al.
Leukemia Research
|
December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy
Yuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.
Leukemia & Lymphoma
|
June 11, 2014
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone
Naoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
May 15, 2015
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy]
Hideyuki Koharazawa, Reina Watanabe, Yukako Hattori, et al.
Cancer Science
|
November 3, 2011
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.
Leukemia & Lymphoma
|
June 9, 2017
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis
Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, et al.
Page
of 3